Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank75
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P75
Within normal range
Average
-2562.78%
Historical baseline
PeriodValueYoY Change
20240.00%-
20230.00%+100.0%
2022-8874.77%-190.6%
2021-3054.25%-245.2%
2020-884.86%-